InvestSMART

Creso Pharma Limited (ASX: CPH) - Announcements

- Current share price for CPH : $0.009

ASX company news and announcements for Creso Pharma Limited (CPH) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Creso Pharma Limited (CPH) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Creso Pharma Limited (CPH), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Creso Pharma Limited (CPH)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Creso Pharma To Be Acquired 7 Jun 2019 8:25AM $0.420 $0.009 fallen by 97.86%
- Release of Securities From Voluntary Escrow 4 Jun 2019 1:17PM $0.410 $0.009 fallen by 97.80%
- Results of Meeting 31 May 2019 6:51PM $0.420 $0.009 fallen by 97.86%
- Creso Harvests First Cannabis Crop in Canada 23 May 2019 8:26AM $0.460 $0.009 fallen by 98.04%
- BHC Distribution Agreement & Australian Import Permit 30 Apr 2019 11:08AM $0.450 $0.009 fallen by 98%
- Quarterly Update & Appendix 4C 29 Apr 2019 5:24PM $0.450 $0.009 fallen by 98%
- Notice of Annual General Meeting/Proxy Form 29 Apr 2019 4:47PM $0.450 $0.009 fallen by 98%
- Brazil Import Licence - Additional Information 23 Apr 2019 6:01PM $0.440 $0.009 fallen by 97.95%
- Brazil Import Licence Granted For cannaQIX 18 Apr 2019 8:27AM $0.460 $0.009 fallen by 98.04%
- Creso Pharma Canadian Cultivation Update 15 Apr 2019 8:21AM $0.435 $0.009 fallen by 97.93%
- Additional Information on Secured Loans 11 Apr 2019 1:41PM $0.435 $0.009 fallen by 97.93%
- Creso to Raise AUD5.35m via Secured Loans 11 Apr 2019 9:38AM $0.405 $0.009 fallen by 97.78%
- Trading Halt 9 Apr 2019 9:22AM $0.405 $0.009 fallen by 97.78%
- Response to ASX Aware Query 5 Apr 2019 10:16AM $0.460 $0.009 fallen by 98.04%
- Commercial Progress Across Premium Product Categories 2 Apr 2019 9:06AM $0.390 $0.009 fallen by 97.69%
- Appendix 4G & Corporate Governance Statement 27 Mar 2019 7:15PM $0.325 $0.009 fallen by 97.23%
- Annual Report to shareholders 25 Mar 2019 8:19AM $0.325 $0.009 fallen by 97.23%
- Release of Securities From Voluntary Escrow 6 Mar 2019 4:11PM $0.375 $0.009 fallen by 97.60%
- CEO's Report on Operations & Appendix 4E 28 Feb 2019 7:43PM $0.387 $0.009 fallen by 97.67%
- Creso Granted License to Cultivate Cannabis 18 Feb 2019 8:42AM $0.385 $0.009 fallen by 97.66%
- Strategic Collaboration for CBD products with Hempmate Switz 14 Feb 2019 8:18AM $0.385 $0.009 fallen by 97.66%
- Strategic Collaboration with Burleigh Heads Cannabis 13 Feb 2019 8:18AM $0.375 $0.009 fallen by 97.60%
- Reinstatement to Official Quotation 12 Feb 2019 9:32AM $0.415 $0.009 fallen by 97.83%
- Clarification and Reinstatement to Trading 12 Feb 2019 9:32AM $0.415 $0.009 fallen by 97.83%
- Suspension Update 6 Feb 2019 2:15PM $0.415 $0.009 fallen by 97.83%

626 - 650 of 891 results

Page 26 of 36

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.